Cargando…
Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423182/ https://www.ncbi.nlm.nih.gov/pubmed/32898320 http://dx.doi.org/10.1002/ctm2.142 |
_version_ | 1783570131270500352 |
---|---|
author | Xu, Siyuan Cheng, Jingning Wei, Bojun Zhang, Yang Li, Yang Zhang, Zongmin Liu, Yang Zhang, Ye Zhang, Rui Wang, Kai Wang, Xiaolei Liu, Shaoyan Huang, Ying Xu, Zhengang Liu, Jie |
author_facet | Xu, Siyuan Cheng, Jingning Wei, Bojun Zhang, Yang Li, Yang Zhang, Zongmin Liu, Yang Zhang, Ye Zhang, Rui Wang, Kai Wang, Xiaolei Liu, Shaoyan Huang, Ying Xu, Zhengang Liu, Jie |
author_sort | Xu, Siyuan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7423182 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74231822020-08-13 Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study Xu, Siyuan Cheng, Jingning Wei, Bojun Zhang, Yang Li, Yang Zhang, Zongmin Liu, Yang Zhang, Ye Zhang, Rui Wang, Kai Wang, Xiaolei Liu, Shaoyan Huang, Ying Xu, Zhengang Liu, Jie Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2020-08-12 /pmc/articles/PMC7423182/ /pubmed/32898320 http://dx.doi.org/10.1002/ctm2.142 Text en © 2020 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to Editor Xu, Siyuan Cheng, Jingning Wei, Bojun Zhang, Yang Li, Yang Zhang, Zongmin Liu, Yang Zhang, Ye Zhang, Rui Wang, Kai Wang, Xiaolei Liu, Shaoyan Huang, Ying Xu, Zhengang Liu, Jie Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study |
title | Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study |
title_full | Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study |
title_fullStr | Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study |
title_full_unstemmed | Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study |
title_short | Development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: A prospective, blinded, multicenter study |
title_sort | development and validation of circulating tumor cells signatures for papillary thyroid cancer diagnosis: a prospective, blinded, multicenter study |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423182/ https://www.ncbi.nlm.nih.gov/pubmed/32898320 http://dx.doi.org/10.1002/ctm2.142 |
work_keys_str_mv | AT xusiyuan developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy AT chengjingning developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy AT weibojun developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy AT zhangyang developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy AT liyang developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy AT zhangzongmin developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy AT liuyang developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy AT zhangye developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy AT zhangrui developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy AT wangkai developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy AT wangxiaolei developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy AT liushaoyan developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy AT huangying developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy AT xuzhengang developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy AT liujie developmentandvalidationofcirculatingtumorcellssignaturesforpapillarythyroidcancerdiagnosisaprospectiveblindedmulticenterstudy |